Contact
searchSearch
HMP Global

Aortic Interventions

Features

Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Interview
Confronting the Gender Gap in AAA Care: Women Face Worse Outcomes and What Needs to Change
02/18/2026
Jon Matsumura, MD
Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.
Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.
Despite advances, women with AAA...
02/18/2026
Vascular Disease Management
John S. Pellerito, MD
ISET 2026
CEUS in Vascular Imaging—EVAR Follow-Up and Beyond
02/09/2026
John S. Pellerito, MD
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his...
02/09/2026
Vascular Disease Management
Dr Tara Mastracci
LINC 2026
How to Start an Endoarch Program in a Cardiothoracic Department
01/29/2026
Tara M. Mastracci, MD
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a...
01/29/2026
Vascular Disease Management
Maria Antonello Ruffino, MD
LINC 2026
Indications, Planning, and Technical Aspects of PMEGs Based on a Cross-Sectional Global Survey
01/29/2026
Maria Antonello Ruffino, MD
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares...
01/29/2026
Vascular Disease Management
Dr Groenenberg
LINC 2026
Augmented Reality for Live Tracking of 3D Stent-Graft Positions During EVAR Surgery
01/28/2026
Annabel Groenenberg, MD
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel...
01/28/2026
Vascular Disease Management
Dr Armando Lobato
LINC 2026
Complex Aortic Dissection: You Either Master It—or It Takes You Down
01/28/2026
Armando Lobato, MD
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today...
01/28/2026
Vascular Disease Management
Moritz Bischoff, MD
LINC 2026
Is 10-Year Follow-Up Really Enough After EVAR?
01/26/2026
Moritz Bischoff, MD
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how...
01/26/2026
Vascular Disease Management
Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management

Videos

Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Joseph Lombardi
ISET 2024
Type B Aortic Dissections: An Update on When and How to Treat
02/29/2024

Joseph Lombardi, MD, FACS
Cooper Medical School of Rowan University, Camden, New Jersey

Joseph Lombardi, MD, FACS Cooper Medi...
In this video, vascular surgeon Dr. Joseph Lombardi discusses his presentation on type B aortic dissections at ISET 2024.
In this video, vascular surgeon Dr. Joseph Lombardi discusses his presentation on type B aortic dissections at ISET 2024.
In this video, vascular surgeon...
02/29/2024
Vascular Disease Management
ISET Lombardi Video
ISET 2023
Type B Aortic Dissections: When to Intervene
02/15/2023
Joseph V. Lombardi, MD, FACS
In this video, Dr. Joseph Lombardi discusses his presentation from ISET 2023 on type B aortic dissections.
In this video, Dr. Joseph Lombardi discusses his presentation from ISET 2023 on type B aortic dissections.
In this video, Dr. Joseph...
02/15/2023
Vascular Disease Management
Dr. Sukgu Han
VIdeo
Achieving Optimal TEVAR Positioning: Advantages and Learnings With the Gore TAG Conformable Thoracic Stent Graft with Active Control System
05/01/2022
Sukgu Han, MD
Dr. Sukgu Han discusses achieving optimal TEVAR positioning in type B dissection.
Dr. Sukgu Han discusses achieving optimal TEVAR positioning in type B dissection.
Dr. Sukgu Han discusses...
05/01/2022
Vascular Disease Management
Dr. Joseph Lombardi
ISET 2022
Approaches to the False Lumen in Type B Dissection
02/23/2022
Joseph V. Lombardi, MD, FACS
In this video from ISET 2022, Dr. Lombardi discusses his presentation on dealing with a false lumen in Type B aortic dissection.
In this video from ISET 2022, Dr. Lombardi discusses his presentation on dealing with a false lumen in Type B aortic dissection.
In this video from ISET 2022,...
02/23/2022
Vascular Disease Management
Dr. Barry Katzen
ISET 2022
TEVAR: Indications and Value of Multidisciplinary Teams
02/22/2022
Barry T. Katzen, MD, FACC, FACR, FSIR
In this video from ISET 2022, Dr. Katzen discusses the importance of multidisciplinary teamwork in thoracic endovascular aortic repair.
In this video from ISET 2022, Dr. Katzen discusses the importance of multidisciplinary teamwork in thoracic endovascular aortic repair.
In this video from ISET 2022,...
02/22/2022
Vascular Disease Management
Gore Video
Video
How Are Unmet Needs in EVAR Being Addressed?
11/24/2021
Erin Moore, MD, FACS, FSVS, RPVI
Dr. Erin Moore shares his thoughts on what those needs are and how a relatively new EVAR device was designed to meet them.
Dr. Erin Moore shares his thoughts on what those needs are and how a relatively new EVAR device was designed to meet them.
Dr. Erin Moore shares his...
11/24/2021
Vascular Disease Management
Dr. Matthew Eagleton
Video
What Is the Value of Internal Iliac Artery Preservation?
10/27/2021
Approximately 25% of all AAA cases extend to the common iliac arteries. What is the value of internal iliac artery preservation?
Approximately 25% of all AAA cases extend to the common iliac arteries. What is the value of internal iliac artery preservation?
Approximately 25% of all AAA...
10/27/2021
Vascular Disease Management
Video
What Is the Appropriate Pre-procedural Evaluation of Patients With Vascular Disorder?
08/24/2020
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this month's video, watch Dr. Walker provide his insight and commentary on the original research from Sultan et al: "Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair."
In this month's video, watch Dr. Walker provide his insight and commentary on the original research from Sultan et al: "Predictive Utility of Preoperative NT-proBNP Levels on Cardiovascular Outcomes of Abdominal Aortic Aneurysm Repair."
In this month's video, watch Dr....
08/24/2020
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management
Michael Pishvaian headshot
Interview
Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
06/15/2026
Michael Pishvaian, MD, PhD
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD,...
06/15/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management

Presentations

John S. Pellerito, MD
ISET 2026
CEUS in Vascular Imaging—EVAR Follow-Up and Beyond
02/09/2026
John S. Pellerito, MD
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his Monday morning session at ISET 2026 with a pragmatic message for vascular specialists: contrast-enhanced ultrasound (CEUS) is no longer a niche add-on in the vascular lab.
John S. Pellerito, MD, began his...
02/09/2026
Vascular Disease Management
Dr Tara Mastracci
LINC 2026
How to Start an Endoarch Program in a Cardiothoracic Department
01/29/2026
Tara M. Mastracci, MD
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a glimpse of her extensive experience shaping a multidisciplinary endoarch service within a cardiothoracic setting.
Dr Tara Mastracci shares a...
01/29/2026
Vascular Disease Management
Maria Antonello Ruffino, MD
LINC 2026
Indications, Planning, and Technical Aspects of PMEGs Based on a Cross-Sectional Global Survey
01/29/2026
Maria Antonello Ruffino, MD
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares insights from a cross-sectional survey that maps where consensus exists, where indications and planning thresholds diverge, and how geography and operator volume shape decision-making.
Maria Antonello Ruffino shares...
01/29/2026
Vascular Disease Management
Dr Groenenberg
LINC 2026
Augmented Reality for Live Tracking of 3D Stent-Graft Positions During EVAR Surgery
01/28/2026
Annabel Groenenberg, MD
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel Groenenberg about her team’s LAMARR concept, which aims to provide live intraoperative 3D tracking of stent-graft position from a single fluoroscopy image.
LINC Today spoke with Dr Annabel...
01/28/2026
Vascular Disease Management
Dr Armando Lobato
LINC 2026
Complex Aortic Dissection: You Either Master It—or It Takes You Down
01/28/2026
Armando Lobato, MD
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today regarding his presentation, Dr Armando Lobato set out a practical framework for decision-making in complicated acute type B and hybrid post-arch scenarios.
In an interview with LINC Today...
01/28/2026
Vascular Disease Management
Moritz Bischoff, MD
LINC 2026
Is 10-Year Follow-Up Really Enough After EVAR?
01/26/2026
Moritz Bischoff, MD
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how late failure modes and sac dynamics should shape risk-adapted surveillance, why patient engagement may be the decisive determinant of long-term safety, and how imaging strategies can be tailored.
Moritz Bischoff discusses how...
01/26/2026
Vascular Disease Management
Chiara Lomazzi and Santi Trimarchi
LINC 2025
10-Year Results of the GREAT Registry: Lessons Learned From More Than 30 Publications
01/29/2025
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara...
01/29/2025
Vascular Disease Management
Dr Tsilimparis
LINC 2024
Physician-modified Endografts on Trial
05/30/2024

Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany

Nikolaos Tsilimparis, MD University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified...
05/30/2024
Vascular Disease Management
Dr Donas
LINC 2023
EnChEVAR: A Force for Standardization
06/08/2023
Konstantinos Donas, MD
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’...
06/08/2023
Vascular Disease Management
Dr Verhagen
LINC 2023
Trial Set to ADVANCE Knowledge in Sac Regression
06/07/2023
Hence Verhagen, MD
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of...
06/07/2023
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
When Economics Meets Innovation: Matching Deep Venous Arterialization to the Right Site of Service
08/07/2026
Mike Watts, MD, FSIR
08/07/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Early Detection and Timely Reintervention Drive Success After Deep Venous Arterialization
08/07/2026
Yana Etkin, MD, FSVS, FACS
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an...
08/07/2026
Vascular Disease Management
Alik Farber, MD
AMP 2026
Four-Year BEST-CLI Data Reinforce a Team-Based Future for Limb Salvage
08/07/2026
Alik Farber, MD
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented...
08/07/2026
Vascular Disease Management
Dr Eric Secemsky
AMP 2026
Defining Optimal Medical Therapy for CLTI in 2026
08/07/2026
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a...
08/07/2026
Vascular Disease Management
Dr Ralf Langhoff
AMP 2026
Retrograde Access Moves to the Forefront: Rethinking CTO Crossing Strategies
08/06/2026
Ralf Langhoff, MD
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon...
08/06/2026
Vascular Disease Management
Dr Ramon Varcoe
AMP 2026
Bioresorbable Below-the-Knee Technology Shows Durable Promise for CLTI
08/06/2026
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an...
08/06/2026
Vascular Disease Management
Dr Pradeep Nair
AMP 2026
A New Approach to Crossing and Preparing Complex Peripheral Chronic Total Occlusions
08/06/2026
Pradeep K. Nair, MD, FACC, FSCAI
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the...
08/06/2026
Vascular Disease Management
S Jay Mathews, MD
AMP 2026
SELUTION SLR Highlights the Growing Role of Sirolimus Drug-Eluting Balloons in CLTI
08/06/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the...
08/06/2026
Vascular Disease Management
Tim Wittig, MD
AMP 2026
MOTIV BTK Trial Demonstrates Promising Early Outcomes for Sirolimus-Eluting Bioresorbable Scaffold in CLTI
08/05/2026
Tim Wittig, MD
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the...
08/05/2026
Vascular Disease Management
Dr Eric Scott
AMP 2026
Using Imaging to Choose Between Endovascular Therapy and Surgical Bypass
08/05/2026
Eric C. Scott, MD
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents...
08/05/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management
Press Release
Final Patient Treated in ZENITH® FENESTRATED+ Endovascular Graft Clinical Study
08/28/2025
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL...
08/28/2025
Vascular Disease Management
Aortic Arch Repair
GORE® TAG® Thoracic Branch Endoprosthesis (TBE) Now Indicated for Zone 0 and Zone 1 Aortic Arch Repairs
06/23/2025
The first off-the-shelf, on-label branched endovascular device for Zones 0, 1 and 2 FLAGSTAFF, Ariz. (June 23, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced that the GORE® TAG® Thoracic Branch Endoprosthesis...
The first off-the-shelf, on-label branched endovascular device for Zones 0, 1 and 2 FLAGSTAFF, Ariz. (June 23, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced that the GORE® TAG® Thoracic Branch Endoprosthesis...
The first off-the-shelf,...
06/23/2025
Vascular Disease Management
Aortic Lesions
Gore Announces FDA Approval and First Commercial Implant of Large-Diameter Thoracic Tapers
04/03/2025
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24,...
04/03/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management
AAA Endoprosthesis
First Commercial Implant of the Gore® Excluder® Conformable AAA Endoprosthesis With Active Control System in Canada
01/27/2025
Bringing physicians a new degree of control and conformability FLAGSTAFF, Ariz. (January 10, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced the first commercial use of the GORE® EXCLUDER® Conformable AAA...
Bringing physicians a new degree of control and conformability FLAGSTAFF, Ariz. (January 10, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced the first commercial use of the GORE® EXCLUDER® Conformable AAA...
Bringing physicians a new degree...
01/27/2025
Vascular Disease Management
Press Release
Echo IQ Signs Integration Agreement With Flagship US Hospital
12/12/2024
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the...
12/12/2024
Vascular Disease Management
Bridging Stent for FEVAR
World premiere for Bentley’s BeFlared Bridging Stent: Successful “First in Man” Operation
12/02/2024
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024...
12/02/2024
Vascular Disease Management
Press Release
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
Press Release
Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device
07/24/2026
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026...
07/24/2026
Vascular Disease Management
Thrombectomy
THUNDER Study Demonstrates Penumbra’s THUNDERBOLT is Safe and Effective for Stroke Care
07/22/2026
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif....
07/22/2026
Cath Lab Digest
Stroke Interventions
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
07/17/2026
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026...
07/17/2026
Vascular Disease Management
Liver Tumor Ablation
First Meta-analysis Supports Histotripsy for Liver Tumor Ablation
07/14/2026
Laura Simson, MA
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high...
07/14/2026
Vascular Disease Management
Radiation Safety
Landmark Multi-Society Consensus Signals New Era in Occupational Radiation Safety; Rampart Positioned to Accelerate Adoption of Lead-Free Enhanced Radiation Protection
07/14/2026
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026...
07/14/2026
Vascular Disease Management
GPX Embolic Device
GPX® Embolic Device Meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
07/14/2026
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx...
07/14/2026
Vascular Disease Management
Transarterial Chemoembolization
STRIDE-Based Regimens Plus TACE Improve Outcomes vs TACE Alone in Embolization-Eligible Hepatocellular Carcinoma
07/13/2026
Stephanie Holland
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3...
07/13/2026
Vascular Disease Management
Peripheral Intervention
3-Year DETOUR2 Results Demonstrate Sustained Symptom Relief and Limb Preservation in Complex SFA Disease
07/09/2026
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first...
07/09/2026
Cath Lab Digest
Thrombectomy for Stroke
First Patient Enrolled in Penumbra’s FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
07/07/2026
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc....
07/07/2026
Cath Lab Digest
Embolization
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
07/02/2026
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02,...
07/02/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use